zolpidem has been researched along with alpidem in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (7.69) | 18.7374 |
1990's | 13 (50.00) | 18.2507 |
2000's | 2 (7.69) | 29.6817 |
2010's | 8 (30.77) | 24.3611 |
2020's | 1 (3.85) | 2.80 |
Authors | Studies |
---|---|
Biggio, G; Cagetti, E; Franco, M; Genchi, G; Latrofa, A; Liso, G; Ricciardi, L; Sanna, E; Trapani, G; Tuveri, F | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Soural, M; Vanda, D; Zajdel, P | 1 |
Cerra, B; Gioiello, A; Lozza, AM; Piccinno, A | 1 |
Dessibourg, CA | 1 |
Byrnes, JJ; Greenblatt, DJ; Miller, LG | 1 |
Bianchetti, G; Durand, A; Morselli, PL; Thénot, JP | 1 |
Advenier, C; Candenas, ML; Devillier, P; Naline, E | 1 |
De Luca, C; De Medici, D; Massotti, M | 1 |
Biggio, G; Carcangiu, G; Concas, A; Mereu, G; Passino, N | 1 |
Arbilla, S; Benavides, J; Langer, SZ; Scatton, B | 1 |
Arbilla, S; Langer, SZ | 2 |
Gaillard, Y; Gay-Montchamp, JP; Ollagnier, M | 1 |
Benavides, J; Peny, B; Ruano, D; Scatton, B; Vitorica, J | 1 |
Auta, J; Costa, E; Guidotti, A; Kozikowski, A; Ma, D; Romeo, E | 1 |
Bain, CJ; Kemp, JA; Wafford, KA; Whiting, PJ | 1 |
Kintz, P; Mangin, P; Tracqui, A | 1 |
Betti, L; Bistocchi, M; Giannaccini, G; Gori, M; Lucacchini, A | 1 |
Berson, A; Berthon, B; Descatoire, V; Fau, D; Feldmann, G; Maulny, B; Pessayre, D; Sutton, A; Tordjmann, T; Vadrot, N | 1 |
Chernyak, N; Gevorgyan, V | 1 |
Mobin, SM; Nair, DK; Namboothiri, IN | 1 |
5 review(s) available for zolpidem and alpidem
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases.
Topics: Animals; Clinical Trials as Topic; Drug Design; Humans; Imidazoles; Ligands; Mental Disorders; Molecular Targeted Therapy; Neurodegenerative Diseases; Pyridines | 2019 |
The Medicinal Chemistry in the Era of Machines and Automation: Recent Advances in Continuous Flow Technology.
Topics: Automation; Chemistry, Pharmaceutical; Drug Discovery; Drug Evaluation, Preclinical; Humans | 2020 |
Comparative pharmacokinetic profile of two imidazopyridine drugs: zolpidem and alpidem.
Topics: Animals; Imidazoles; Mice; Pyridines; Rats; Zolpidem | 1992 |
Zolpidem and alpidem: two imidazopyridines with selectivity for omega 1- and omega 3-receptor subtypes.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Binding, Competitive; Chloride Channels; Chlorides; Hypnotics and Sedatives; Imidazoles; Membrane Proteins; Molecular Structure; Pyridines; Receptors, GABA-A; Zolpidem | 1990 |
21 other study(ies) available for zolpidem and alpidem
Article | Year |
---|---|
Synthesis and binding affinity of 2-phenylimidazo[1,2-alpha]pyridine derivatives for both central and peripheral benzodiazepine receptors. A new series of high-affinity and selective ligands for the peripheral type.
Topics: Animals; Benzodiazepinones; Binding, Competitive; Brain; Female; Flunitrazepam; Humans; Hypnotics and Sedatives; Imidazoles; Kidney; Kinetics; Male; Mitochondria; Molecular Structure; Oocytes; Pyridines; Radioligand Assay; Rats; Rats, Wistar; Receptors, GABA-A; Recombinant Proteins; Structure-Activity Relationship; Xenopus laevis; Zolpidem | 1997 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
[Imidazopyridines, an alternative to benzodiazepines].
Topics: Anti-Anxiety Agents; Humans; Hypnotics and Sedatives; Imidazoles; Pyridines; Zolpidem | 1992 |
Benzodiazepine receptor binding of nonbenzodiazepines in vivo: alpidem, zolpidem and zopiclone.
Topics: Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Brain; Cerebellum; Cerebral Cortex; Dose-Response Relationship, Drug; Flumazenil; Hippocampus; Hypnotics and Sedatives; Imidazoles; Male; Mice; Mice, Inbred Strains; Piperazines; Pyridines; Receptors, GABA-A; Reference Values; Zolpidem | 1992 |
Influence of diazepam, alpidem, zolpidem and zopiclone, on the response to adenosine of the guinea pig isolated trachea.
Topics: 2-Chloroadenosine; Adenosine; Animals; Anti-Anxiety Agents; Diazepam; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Guinea Pigs; Histamine; Hypnotics and Sedatives; Imidazoles; Male; Muscle Contraction; Muscle, Smooth; Pyridines; Receptors, GABA-A; Trachea; Zolpidem | 1991 |
Relative efficacies of benzodiazepine receptor agonists in affecting red nucleus electrical activity in rabbits.
Topics: Animals; Bicuculline; Clonazepam; Diazepam; Dose-Response Relationship, Drug; Flumazenil; Flunitrazepam; Imidazoles; Isoquinolines; Male; Pentylenetetrazole; Pyridazines; Pyridines; Rabbits; Receptors, GABA-A; Red Nucleus; Zolpidem | 1990 |
Reduction of reticulata neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type I benzodiazepine receptors.
Topics: Action Potentials; Animals; Anti-Anxiety Agents; Diazepam; Flumazenil; Hypnotics and Sedatives; Imidazoles; Male; Neurons; Pyridines; Rats; Rats, Inbred Strains; Receptors, GABA-A; Reticular Formation; Zolpidem | 1990 |
Limitations of the benzodiazepine receptor nomenclature: a proposal for a pharmacological classification as omega receptor subtypes.
Topics: Animals; Benzodiazepinones; Cerebellum; Diazepam; Imidazoles; Kidney; Pyridines; Rats; Receptors, GABA-A; Spinal Cord; Terminology as Topic; Zolpidem | 1988 |
Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes.
Topics: Animals; Brain Chemistry; Flunitrazepam; GABA-A Receptor Antagonists; Imidazoles; In Vitro Techniques; Isoquinolines; Kidney; Ligands; Pyridazines; Pyridines; Rats; Receptors, GABA-A; Spinal Cord; Terminology as Topic; Zolpidem | 1988 |
Simultaneous screening and quantitation of alpidem, zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection after solid-phase extraction.
Topics: Anti-Anxiety Agents; Benzodiazepines; Buspirone; Chromatography, Gas; Electrochemistry; Humans; Hypnotics and Sedatives; Imidazoles; Indicators and Reagents; Pyridines; Regression Analysis; Zolpidem | 1993 |
Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem.
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Autoradiography; Binding, Competitive; Brain; Flumazenil; Hypnotics and Sedatives; Imidazoles; Kinetics; Male; Organ Specificity; Pyridazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Spinal Cord; Tritium; Zolpidem | 1993 |
Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives.
Topics: Aggression; Allosteric Regulation; Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Clonazepam; Desoxycorticosterone; Flumazenil; Imidazoles; Indoleacetic Acids; Isoniazid; Isoquinolines; Mitochondria; Phobic Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, GABA-A; Seizures; Zolpidem | 1993 |
Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors.
Topics: Animals; Anti-Anxiety Agents; Base Sequence; Benzodiazepines; Binding Sites; DNA; Humans; Hypnotics and Sedatives; Imidazoles; Molecular Sequence Data; Oocytes; Pyridines; Receptors, GABA-A; Recombinant Proteins; Xenopus laevis; Zolpidem | 1993 |
High-performance liquid chromatographic assay with diode-array detection for toxicological screening of zopiclone, zolpidem, suriclone and alpidem in human plasma.
Topics: Adult; Anti-Anxiety Agents; Azabicyclo Compounds; Chromatography, High Pressure Liquid; Female; Humans; Hydrogen-Ion Concentration; Hypnotics and Sedatives; Imidazoles; Naphthyridines; Piperazines; Pyridines; Spectrophotometry, Ultraviolet; Sulfur Compounds; Zolpidem | 1993 |
[3H]Ro 15-1788 binding sites to brain membrane of the saltwater Mugil cephalus.
Topics: Animals; Binding Sites; Binding, Competitive; Brain; Carbolines; Cell Membrane; Chlorides; Diazepam; Female; Fishes; Flumazenil; Flunitrazepam; gamma-Aminobutyric Acid; Imidazoles; Ionophores; Male; Pyridines; Receptors, GABA-A; Synaptosomes; Tritium; Zolpidem | 2001 |
Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem, in rat hepatocytes: role of mitochondrial permeability transition and metabolic activation.
Topics: Adenosine Diphosphate; Animals; Anti-Anxiety Agents; Biotransformation; Cells, Cultured; Cytochrome c Group; GABA-A Receptor Agonists; Hepatocytes; Imidazoles; Male; Membrane Potentials; Mitochondria, Liver; Oxidation-Reduction; Oxygen Consumption; Permeability; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Zolpidem | 2001 |
General and efficient copper-catalyzed three-component coupling reaction towards imidazoheterocycles: one-pot synthesis of alpidem and zolpidem.
Topics: Anti-Anxiety Agents; Catalysis; Copper; Cyclization; Heterocyclic Compounds; Imidazoles; Pyridines; Pyrimidines; Quinolines; Zolpidem | 2010 |
Synthesis of imidazopyridines from the Morita-Baylis-Hillman acetates of nitroalkenes and convenient access to Alpidem and Zolpidem.
Topics: Acetates; Alkenes; Catalysis; Combinatorial Chemistry Techniques; Imidazoles; Molecular Structure; Nitro Compounds; Pyridines; Stereoisomerism; Zolpidem | 2012 |